RespireRx Pharmaceuticals Announces Preliminary Top-Line Analysis of Data from Duke University Phase 2A Clinical Trial of CX1739
LAURION Broadens Advisor Network and Issues Stock Options to First Nations under Amended Exploration Agreement as Ishkoday Exploration Progresses